Additional file 3: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Additional file 1: Tables S1âS9. of The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA

Robert Suruki (443240)
Jonas Daugherty (3968018)
Nada Boudiaf (3968015)
Frank Albers (3946886)

April 2017

Additional results for patient demographics and baseline characteristics, exacerbation rates, exacer...

Additional file 1: of Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function

Collin Brooks (4642354)
Christine Van Dalen (4642351)
Elizabeth Harding (4642357)
Ian Hermans (4642360)
Jeroen Douwes (445627)

December 2017

Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...

Additional file 3: of Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma

Guido Lopes dos Santos Santiago (132669)
Guy Brusselle (335931)
Kenny Dauwe (481142)
Pieter Deschaght (257253)
Chris Verhofstede (80733)
Dries Vaneechoutte (671973)
Ellen Deschepper (130165)
Paul Jordens (4016111)
Guy Joos (2576104)
Mario Vaneechoutte (40273)

May 2017

Beta diversity analysis of the oropharyngeal microbiomes of the azithromycin-treated patients: visit...

Additional file 1: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...

Additional file 2: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB

Additional file 8: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...

Additional file 4: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Adjusted treatment differences from baseline in trough FEV1 at Week 12 (Efficacy population). (DOCX ...

Additional file 9: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...

Additional file 6: Table S3. of Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Jean Bousquet (20909)
Neil Barnes (3604997)
Michael Gibbs (3988391)
Nadeem Gul (3988394)
Susan Tomkins (3988397)
Xin Zhou (54275)
Young-Joo Cho (504038)
Hae-Sim Park (678741)
William Busse (3466799)
Nanshan Zhong (46591)

April 2017

Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...

Additional file 5: Figure S2. of Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Jean Bousquet (20909)
Neil Barnes (3604997)
Michael Gibbs (3988391)
Nadeem Gul (3988394)
Susan Tomkins (3988397)
Xin Zhou (54275)
Young-Joo Cho (504038)
Hae-Sim Park (678741)
William Busse (3466799)
Nanshan Zhong (46591)

April 2017

Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...

Additional file 1: of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

List of institutions and Independent Ethics Committees/Institutional Review Boards for Study DB21161...

Additional file 1: of Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

George Bardsley (5511125)
Peter Daley-Yates (4332277)
Amanda Baines (5511122)
Rodger Kempsford (5511116)
Mathew Williams (460953)
Tony Mallon (5511131)
Irene Braithwaite (463107)
Kylie Riddell (5511128)
Shashidhar Joshi (5511113)
Philippe Bareille (5511119)
Richard Beasley (239695)
James Fingleton (3728818)

July 2018

Supplementary appendix: The anti-inflammatory duration of action of fluticasone furoate/vilanterol t...

Additional file 1: of Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthmaâmixed treatment comparisons of clinical efficacy

Henrik Svedsater (3469295)
Gillian Stynes (3469289)
Jaro Wex (3469301)
Lucy Frith (3469304)
David Leather (3469286)
Emanuela Castelnuovo (3469298)
Michelle Detry (3469292)
Scott Berry (32788)

February 2016

e-table 1: Characteristics of the studies and treatment arms included in the MTC. e-table 2: Results...

Additional file 3: of Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic

Adnan Azim (549482)
Heena Mistry (6737918)
Anna Freeman (6737921)
Clair Barber (6737927)
Colin Newell (6112010)
Kerry Gove (6737930)
Yvette Thirlwall (6737933)
Matt Harvey (672827)
Kimberley Bentley (6737936)
Deborah Knight (59524)
Karen Long (6737939)
Frances Mitchell (6737942)
Yueqing Cheng (6737945)
Judit Varkonyi-Sepp (6737948)
Wolfgang Grabau (6737951)
Paddy Dennison (6737954)
Hans Haitchi (6737957)
S. Arshad (3564908)
Ratko Djukanovic (3167016)
Tom Wilkinson (3497267)
Peter Howarth (707031)
Ramesh Kurukulaaratchy (5771609)

May 2019

Appendix A Clinical Investigations. Appendix B Lung Function Test. Appendix C Biobank Samples. (DOCX...

Additional file 1: of Impact of two oral doses of 100,000âIU of vitamin D3 in preschoolers with viral-induced asthma: a pilot randomised controlled trial

Francine Ducharme (3442106)
Megan Jensen (119036)
GeneviĂ¨ve Mailhot (6374540)
Nathalie Alos (3536846)
John White (269203)
Elizabeth Rousseau (3536843)
Sze Tse (6374534)
Ali Khamessan (3536849)
Benjamin Vinet (6374537)

February 2019

Consolidated Standards of Reporting Trials (CONSORT) 2010 checklist of information to include when r...

Additional file 1: Tables S1âS9. of The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA

Robert Suruki (443240)
Jonas Daugherty (3968018)
Nada Boudiaf (3968015)
Frank Albers (3946886)

April 2017

Additional results for patient demographics and baseline characteristics, exacerbation rates, exacer...

Additional file 1: of Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function

Collin Brooks (4642354)
Christine Van Dalen (4642351)
Elizabeth Harding (4642357)
Ian Hermans (4642360)
Jeroen Douwes (445627)

December 2017

Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...

Additional file 3: of Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma

Guido Lopes dos Santos Santiago (132669)
Guy Brusselle (335931)
Kenny Dauwe (481142)
Pieter Deschaght (257253)
Chris Verhofstede (80733)
Dries Vaneechoutte (671973)
Ellen Deschepper (130165)
Paul Jordens (4016111)
Guy Joos (2576104)
Mario Vaneechoutte (40273)

May 2017

Beta diversity analysis of the oropharyngeal microbiomes of the azithromycin-treated patients: visit...

Additional file 1: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Profile of the three Phase III studies included in both the efficacy and safety analyses. (DOCX 47.4...

Additional file 2: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Profile of the two additional Phase IIb studies included in only the safety analyses. (DOCX 25.6 KB

Additional file 8: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

AEs reported by âĽ3 patients in the Japan+Korea cohort of any relevant treatment arm and the corres...

Additional file 4: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Adjusted treatment differences from baseline in trough FEV1 at Week 12 (Efficacy population). (DOCX ...

Additional file 9: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Annette Gross (713794)
Caroline Goldfrad (56320)
Soichiro Hozawa (3480056)
Mark James (816994)
Christine Clifton (3480062)
Yutaro Sugiyama (3480059)
Loretta Jacques (810725)

December 2015

Region ratios of ‘treatment effect’ in Japan+Korea and Not-Japan+Korea patients, where ‘treatment ef...

Additional file 6: Table S3. of Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Jean Bousquet (20909)
Neil Barnes (3604997)
Michael Gibbs (3988391)
Nadeem Gul (3988394)
Susan Tomkins (3988397)
Xin Zhou (54275)
Young-Joo Cho (504038)
Hae-Sim Park (678741)
William Busse (3466799)
Nanshan Zhong (46591)

April 2017

Summary of the most common adverse events (âĽ5%) in the Asian and non-Asian populations. (DOCX 24 k...

Additional file 5: Figure S2. of Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Jean Bousquet (20909)
Neil Barnes (3604997)
Michael Gibbs (3988391)
Nadeem Gul (3988394)
Susan Tomkins (3988397)
Xin Zhou (54275)
Young-Joo Cho (504038)
Hae-Sim Park (678741)
William Busse (3466799)
Nanshan Zhong (46591)

April 2017

Asthma quality of life questionnaire score (pooled data) in Asian and non-Asian patients, at baselin...

Additional file 1: of Umeclidinium/vilanterol versus fluticasone propionate/salmeterol in COPD: a randomised trial

Dave Singh (114223)
Sally Worsley (3573320)
Chang-Qing Zhu (3573326)
Liz Hardaker (3573323)
Alison Church (811460)

August 2015

List of institutions and Independent Ethics Committees/Institutional Review Boards for Study DB21161...

Additional file 1: of Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

George Bardsley (5511125)
Peter Daley-Yates (4332277)
Amanda Baines (5511122)
Rodger Kempsford (5511116)
Mathew Williams (460953)
Tony Mallon (5511131)
Irene Braithwaite (463107)
Kylie Riddell (5511128)
Shashidhar Joshi (5511113)
Philippe Bareille (5511119)
Richard Beasley (239695)
James Fingleton (3728818)

July 2018

Supplementary appendix: The anti-inflammatory duration of action of fluticasone furoate/vilanterol t...

Additional file 1: of Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthmaâmixed treatment comparisons of clinical efficacy

Henrik Svedsater (3469295)
Gillian Stynes (3469289)
Jaro Wex (3469301)
Lucy Frith (3469304)
David Leather (3469286)
Emanuela Castelnuovo (3469298)
Michelle Detry (3469292)
Scott Berry (32788)

February 2016

e-table 1: Characteristics of the studies and treatment arms included in the MTC. e-table 2: Results...

Additional file 3: of Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic

Adnan Azim (549482)
Heena Mistry (6737918)
Anna Freeman (6737921)
Clair Barber (6737927)
Colin Newell (6112010)
Kerry Gove (6737930)
Yvette Thirlwall (6737933)
Matt Harvey (672827)
Kimberley Bentley (6737936)
Deborah Knight (59524)
Karen Long (6737939)
Frances Mitchell (6737942)
Yueqing Cheng (6737945)
Judit Varkonyi-Sepp (6737948)
Wolfgang Grabau (6737951)
Paddy Dennison (6737954)
Hans Haitchi (6737957)
S. Arshad (3564908)
Ratko Djukanovic (3167016)
Tom Wilkinson (3497267)
Peter Howarth (707031)
Ramesh Kurukulaaratchy (5771609)

May 2019

Appendix A Clinical Investigations. Appendix B Lung Function Test. Appendix C Biobank Samples. (DOCX...

Additional file 1: of Impact of two oral doses of 100,000âIU of vitamin D3 in preschoolers with viral-induced asthma: a pilot randomised controlled trial

Francine Ducharme (3442106)
Megan Jensen (119036)
GeneviĂ¨ve Mailhot (6374540)
Nathalie Alos (3536846)
John White (269203)
Elizabeth Rousseau (3536843)
Sze Tse (6374534)
Ali Khamessan (3536849)
Benjamin Vinet (6374537)

February 2019

Consolidated Standards of Reporting Trials (CONSORT) 2010 checklist of information to include when r...

Additional file 1: Tables S1âS9. of The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA

Robert Suruki (443240)
Jonas Daugherty (3968018)
Nada Boudiaf (3968015)
Frank Albers (3946886)

April 2017

Additional results for patient demographics and baseline characteristics, exacerbation rates, exacer...

Additional file 1: of Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function

Collin Brooks (4642354)
Christine Van Dalen (4642351)
Elizabeth Harding (4642357)
Ian Hermans (4642360)
Jeroen Douwes (445627)

December 2017

Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...

Additional file 3: of Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma

Guido Lopes dos Santos Santiago (132669)
Guy Brusselle (335931)
Kenny Dauwe (481142)
Pieter Deschaght (257253)
Chris Verhofstede (80733)
Dries Vaneechoutte (671973)
Ellen Deschepper (130165)
Paul Jordens (4016111)
Guy Joos (2576104)
Mario Vaneechoutte (40273)

May 2017

Beta diversity analysis of the oropharyngeal microbiomes of the azithromycin-treated patients: visit...

Additional file 3: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Abstract

Extracted data

Additional file 3: of Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials

Abstract

Extracted data

Related items

Related items